Krupka Dominik, Rakoczy Katarzyna, Chełmoński Adam, Zakliczyński Michał, Przybylski Roman, Sokolski Mateusz
Student Scientific Club of Transplantology and Advanced Therapies of Heart Failure, Institute of Heart Diseases, Faculty of Medicine, Wrocław Medical University, Wrocław, Poland.
Jan Mikulicz Radecki University Hospital, Wrocław, Poland.
Am J Case Rep. 2025 Aug 18;26:e947439. doi: 10.12659/AJCR.947439.
BACKGROUND Kearns-Sayre syndrome (KSS) is a rare genetic, mitochondrial disorder characterized by a triad of chronic progressive external ophthalmoplegia, pigmentary retina degeneration, and cardiac conduction disorders, with onset before the age of 20 years. The disease can also manifest as several cardiovascular (CV) disorders, such as conduction disorders or dilated cardiomyopathy, along with neuromuscular and endocrinological complications. CASE REPORT A 46-year-old man diagnosed with KSS was admitted to the Institute of Heart Diseases in the qualification process for heart transplantation (Htx). The patient's medical history began with a diagnosis of third-degree atrioventricular block, treated with pacemaker (PM) implantation at age 25. However, due to progressing left ventricle (LV) function deterioration, PM was upgraded to cardiac resynchronization therapy with defibrillator 10 years later. In the year before the admission, he had undergone 2 hospitalizations caused by acute decompensations of heart failure (ADHF). Upon admission, physical examination revealed features of congestion. Transthoracic echocardiography showed an enlarged LV with global hypokinesia, reduced ejection fraction, and right ventricle dysfunction. Due to the neurological complications and poor functional condition, the Heart Team qualified him for conservative treatment. The next hospitalization due to ADHF ended in the patient's death. CONCLUSIONS CV disorders are an important aspect of treatment of KSS patients. Our patient was referred with excessively developed complications, so he could not benefit from Htx or mechanical circulatory support. This case highlights the importance of early diagnosis and monitoring of KSS patients before the full development of complications, including HF.
卡恩斯-塞尔综合征(KSS)是一种罕见的遗传性线粒体疾病,其特征为慢性进行性眼外肌麻痹、色素性视网膜变性和心脏传导障碍三联征,发病年龄在20岁之前。该疾病还可表现为多种心血管(CV)疾病,如传导障碍或扩张型心肌病,以及神经肌肉和内分泌并发症。
一名46岁被诊断为KSS的男性在心脏移植(Htx)资格评估过程中被收入心脏病研究所。患者的病史始于25岁时被诊断为三度房室传导阻滞,并接受了起搏器(PM)植入治疗。然而,由于左心室(LV)功能逐渐恶化,10年后PM升级为带除颤器的心脏再同步治疗。入院前一年,他因心力衰竭急性失代偿(ADHF)住院2次。入院时,体格检查发现有充血体征。经胸超声心动图显示左心室扩大,整体运动减弱,射血分数降低,右心室功能障碍。由于神经并发症和功能状态较差,心脏团队认为他适合保守治疗。因ADHF再次住院最终导致患者死亡。
心血管疾病是KSS患者治疗的一个重要方面。我们的患者转诊时并发症已经非常严重,因此无法从心脏移植或机械循环支持中获益。该病例强调了在包括心力衰竭在内的并发症全面发展之前对KSS患者进行早期诊断和监测的重要性。